GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (HKSE:06669) » Definitions » Piotroski F-Score

Acotec Scientific Holdings (HKSE:06669) Piotroski F-Score : 2 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Acotec Scientific Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Acotec Scientific Holdings's Piotroski F-Score or its related term are showing as below:

HKSE:06669' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 2   Max: 6
Current: 2

During the past 5 years, the highest Piotroski F-Score of Acotec Scientific Holdings was 6. The lowest was 2. And the median was 2.


Acotec Scientific Holdings Piotroski F-Score Historical Data

The historical data trend for Acotec Scientific Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings Piotroski F-Score Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 6.00 2.00 2.00

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only 6.00 N/A 2.00 - 2.00

Competitive Comparison of Acotec Scientific Holdings's Piotroski F-Score

For the Medical Devices subindustry, Acotec Scientific Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acotec Scientific Holdings's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Acotec Scientific Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was HK$15.8 Mil.
Cash Flow from Operations was HK$-14.1 Mil.
Revenue was HK$518.3 Mil.
Gross Profit was HK$412.8 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (1575.176 + 1762.14) / 2 = HK$1668.658 Mil.
Total Assets at the begining of this year (Dec22) was HK$1,575.2 Mil.
Long-Term Debt & Capital Lease Obligation was HK$216.6 Mil.
Total Current Assets was HK$1,324.7 Mil.
Total Current Liabilities was HK$127.1 Mil.
Net Income was HK$78.3 Mil.

Revenue was HK$441.7 Mil.
Gross Profit was HK$375.6 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (1600.827 + 1575.176) / 2 = HK$1588.0015 Mil.
Total Assets at the begining of last year (Dec21) was HK$1,600.8 Mil.
Long-Term Debt & Capital Lease Obligation was HK$39.7 Mil.
Total Current Assets was HK$1,403.1 Mil.
Total Current Liabilities was HK$110.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Acotec Scientific Holdings's current Net Income (TTM) was 15.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Acotec Scientific Holdings's current Cash Flow from Operations (TTM) was -14.1. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=15.846/1575.176
=0.01005983

ROA (Last Year)=Net Income/Total Assets (Dec21)
=78.329/1600.827
=0.04893033

Acotec Scientific Holdings's return on assets of this year was 0.01005983. Acotec Scientific Holdings's return on assets of last year was 0.04893033. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Acotec Scientific Holdings's current Net Income (TTM) was 15.8. Acotec Scientific Holdings's current Cash Flow from Operations (TTM) was -14.1. ==> -14.1 <= 15.8 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=216.633/1668.658
=0.12982469

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=39.667/1588.0015
=0.0249792

Acotec Scientific Holdings's gearing of this year was 0.12982469. Acotec Scientific Holdings's gearing of last year was 0.0249792. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=1324.702/127.146
=10.41874695

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=1403.083/110.192
=12.733075

Acotec Scientific Holdings's current ratio of this year was 10.41874695. Acotec Scientific Holdings's current ratio of last year was 12.733075. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Acotec Scientific Holdings's number of shares in issue this year was 301.078. Acotec Scientific Holdings's number of shares in issue last year was 299.612. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=412.809/518.285
=0.79649035

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=375.61/441.711
=0.85035238

Acotec Scientific Holdings's gross margin of this year was 0.79649035. Acotec Scientific Holdings's gross margin of last year was 0.85035238. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=518.285/1575.176
=0.32903307

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=441.711/1600.827
=0.27592676

Acotec Scientific Holdings's asset turnover of this year was 0.32903307. Acotec Scientific Holdings's asset turnover of last year was 0.27592676. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+0+0+0+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Acotec Scientific Holdings has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Acotec Scientific Holdings  (HKSE:06669) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Acotec Scientific Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Acotec Scientific Holdings (HKSE:06669) Business Description

Traded in Other Exchanges
Address
16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.

Acotec Scientific Holdings (HKSE:06669) Headlines

No Headlines